Sortino ratio is not yet available for FNCH. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar stocks
The table compares Finch Therapeutics Group, Inc.'s Sortino Ratio with other stocks in the Biotechnology industry across multiple time periods, showing how FNCH's risk-adjusted performance compares to industry peers.
Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jul 22, 2026.
| Symbol | Name | 1Y Sortino Ratio | 5Y Sortino Ratio | 10Y Sortino Ratio | All Time Sortino Ratio |
|---|---|---|---|---|---|
| ANEB | Anebulo Pharmaceuticals, Inc. | 558.38 | |||
| CARM | Carisma Therapeutics Inc. | 76.20 | |||
| ABVX | Abivax SA American Depositary Shares | 12.67 | |||
| NKGN | NKGen Biotech Inc. Common Stock | 7.55 | |||
| ALMS | Alumis Inc | 6.60 | |||
| CAPR | Capricor Therapeutics, Inc. | 6.56 | |||
| RVMDW | Revolution Medicines Inc. Warrant | 6.41 | |||
| ROIV | Roivant Sciences Ltd. | 6.37 | |||
| RVMD | Revolution Medicines, Inc. | 6.32 | |||
| PRAX | Praxis Precision Medicines, Inc. | 6.14 | |||
| FNCH | Finch Therapeutics Group, Inc. | — |
Historical Sortino Ratio
The chart shows FNCH's rolling Sortino ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to downside risk, while declining trends may signal deteriorating risk-adjusted performance or increased volatility during market stress. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.
Identify market cycles by observing when FNCH consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.
Loading charts...
IHow does FNCH fit in your portfolio?
Add your other holdings to see your portfolio's Sortino Ratio and find out.
Analyze Your Portfolio